Tuesday, January 25, 2011 by: Tony Isaacs, citizen journalist
The more sexually active a woman is, the greater the chances she will become exposed to HPV viruses. Likewise, the older a woman is the more sexual encounters she will likely have had and thus the greater the risk of HPV exposure. Information provided for the Vaccines and Related Biological Products Advisory Committee (VRBPAC) in May 2006 revealed that when the vaccine is administered to a woman with a dormant or harmless form of HPV, the virus can become activated, increasing the likelihood of precancerous lesions developing by a staggering 44.6 percent.
Not one to let negative study results stand in the way of a highly profitable cash cow drug (see Vioxx), Merck decided that the groups in the study were “unbalanced” and played with the figures to eliminate women who were at higher risk to begin with. After the figure juggling the added risk was estimated to be only 11 percent.
Merck initially reported to the FDA that “it is not known whether Gardasil can cause fetal harm when administered to a pregnant woman” and continues to downplay risks for expectant mothers. However, studies have shown that pregnant women have a higher risk for adverse reactions, including miscarriages. The Vaccine Adverse Event Reporting System (VAERS) has reported 45 cases of spontaneous abortion, or miscarriage, following vaccination with Gardasil. At the time the vaccine was approved, five babies had been born with congenital birth defects after their mothers had been immunized with Gardasil, as opposed to a placebo group that had zero. Later reports put the number of birth defects in the vaccinated group closer to 40.